Skip to main content
Top
Published in: Pediatric Cardiology 1/2013

01-01-2013 | Original Article

Comparison of the Efficacy of Different-Sized Amplatzer Duct Occluders (I, II, and II AS) in Children Weighing Less Than 10 kg

Authors: Osman Baspinar, Ahmet Irdem, Ercan Sivasli, Derya Aydin Sahin, Metin Kilinc

Published in: Pediatric Cardiology | Issue 1/2013

Login to get access

Abstract

The transcatheter closure of patent ductus arteriosus (PDA) may cause more complications in small children. Amplatzer (St. Jude Medical, Plymouth, MN) has produces three types of devices for ductal occlusion: the Amplatzer duct occluder I (ADO I) and II (ADO II) and the recently introduced ADO II additional sizes (ADO II AS). We performed this study to determine the efficacy and complication rates in children who weigh <10 kg for the three types of devices used in our clinic. Between February 2007 and March 2012, 77 patients weighing <10 kg had their PDAs occluded with ADOs. The mean age of the patients was 0.76 ± 0.44 years (range 17 days–2 years), and their mean weight was 6.73 ± 2.05 (range 1.2–9.9) kg. In total, 54 girls (70.1 %) and 23 boys (29.9 %) with a mean pulmonary ductus diameter of 2.55 ± 1.0 (1.08–5.94) mm were included in the study. The ADO I was used in 26 patients (33.8 %); the ADO II was used in 43 patients (55.8 %); and the ADO II AS was used in 8 patients (10.4 %). The mean ages of patients with the ADO I, ADO II, and ADO II AS were 1.07 ± 0.48, 0.66 ± 0.31, and 0.28 ± 0.17 years (p < 0.05), respectively. Their mean weights were 7.86 ± 1.45, 6.50 ± 1.85, and 4.36 ± 2.49 kg (p < 0.05), respectively. Their mean narrowest ductal diameters were 3.11 ± 0.96, 2.25 ± 1.06, and 2.33 ± 1.01 mm (p < 0.05), respectively. The use of the ADO II and ADO II AS was found to be more common in type C defects. One patient with the ADO I and 5 patients with the ADO II (7.8 %) developed varying degrees of left pulmonary artery stenosis or iatrogenic aortic coarctation. In 1 patient, the ADO II AS was replaced with the ADO II due to a significant residual shunt observed during the procedure. Each of the ADOs has its own advantages and disadvantages. Although the ADO I is convenient for medium- and large-sized defects, the ADO II and ADO II AS can be used both anterogradely and retrogradely. The ADO II AS is safe and efficient to use in small infants.
Literature
1.
go back to reference Bass JL, Wilson N (2011) Transcatheter occlusion of the patent ductus arteriorus in infants—experimental testing of a new Amplatzer device. Catheter Cardiovasc Interv. doi:10.1002/ccd.22931 Bass JL, Wilson N (2011) Transcatheter occlusion of the patent ductus arteriorus in infants—experimental testing of a new Amplatzer device. Catheter Cardiovasc Interv. doi:10.​1002/​ccd.​22931
2.
go back to reference Bentham J, Meur S, Hudsmith L, Archer N, Wilson N (2011) Echocardiographically guided catheter closure of arterial ducts in small preterm infants on the neonatal intensive care unit. Catheter Cardiovasc Interv 77:409–415PubMedCrossRef Bentham J, Meur S, Hudsmith L, Archer N, Wilson N (2011) Echocardiographically guided catheter closure of arterial ducts in small preterm infants on the neonatal intensive care unit. Catheter Cardiovasc Interv 77:409–415PubMedCrossRef
3.
go back to reference Bhole V, Miller P, Mehta C, Stumper O, Reinhardt Z, De Giovanni JV (2009) Clinical evaluation of the new Amplatzer duct occluder II for patent arterial duct occlusion. Catheter Cardiovasc Interv 74:762–769PubMedCrossRef Bhole V, Miller P, Mehta C, Stumper O, Reinhardt Z, De Giovanni JV (2009) Clinical evaluation of the new Amplatzer duct occluder II for patent arterial duct occlusion. Catheter Cardiovasc Interv 74:762–769PubMedCrossRef
4.
go back to reference Brunetti MA, Ringel R, Owada C, Coulson J, Jennings JM, Hoyer MH et al (2010) Percutaneous closure of patent ductus arteriosus: a multi-institutional registry comparing multiple devices. Catheter Cardiovasc Interv 76:696–702PubMedCrossRef Brunetti MA, Ringel R, Owada C, Coulson J, Jennings JM, Hoyer MH et al (2010) Percutaneous closure of patent ductus arteriosus: a multi-institutional registry comparing multiple devices. Catheter Cardiovasc Interv 76:696–702PubMedCrossRef
5.
go back to reference Butera G, De Rosa G, Chessa M, Piazza L, Delogu A, Frigiola A et al (2004) Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children. Heart 90:1467–1470PubMedCrossRef Butera G, De Rosa G, Chessa M, Piazza L, Delogu A, Frigiola A et al (2004) Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children. Heart 90:1467–1470PubMedCrossRef
6.
go back to reference Celiker A, Aypar E, Karagoz T, Dilber E, Ceviz N (2005) Transcatheter closure of patent ductus arteriosus with Nit-Occlud coils. Catheter Cardiovasc Interv 65:569–576PubMedCrossRef Celiker A, Aypar E, Karagoz T, Dilber E, Ceviz N (2005) Transcatheter closure of patent ductus arteriosus with Nit-Occlud coils. Catheter Cardiovasc Interv 65:569–576PubMedCrossRef
7.
go back to reference Dimas VV, Takao C, Ing FF, Mattamal R, Nugent AW, Grifka RG et al (2010) Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing ≤6 kg. JACC Cardiovasc Interv 3:1295–1299PubMedCrossRef Dimas VV, Takao C, Ing FF, Mattamal R, Nugent AW, Grifka RG et al (2010) Outcomes of transcatheter occlusion of patent ductus arteriosus in infants weighing ≤6 kg. JACC Cardiovasc Interv 3:1295–1299PubMedCrossRef
8.
go back to reference Dua J, Chessa M, Piazza L, Negura D, Micheletti A, Bussadori C et al (2009) Initial experience with the new Amplatzer duct occluder II. J Invasive Cardiol 21:401–405PubMed Dua J, Chessa M, Piazza L, Negura D, Micheletti A, Bussadori C et al (2009) Initial experience with the new Amplatzer duct occluder II. J Invasive Cardiol 21:401–405PubMed
9.
go back to reference Faella HJ, Hijazi ZM (2000) Closure of the patent ductus arteriosus with the Amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv 51:50–54PubMedCrossRef Faella HJ, Hijazi ZM (2000) Closure of the patent ductus arteriosus with the Amplatzer PDA device: immediate results of the international clinical trial. Catheter Cardiovasc Interv 51:50–54PubMedCrossRef
10.
go back to reference Forsey J, Kenny D, Morgan G, Hayes A, Turner M, Tometzki A et al (2009) Early clinical experience with the new Amplatzer duct occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv 74:615–623PubMedCrossRef Forsey J, Kenny D, Morgan G, Hayes A, Turner M, Tometzki A et al (2009) Early clinical experience with the new Amplatzer duct occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv 74:615–623PubMedCrossRef
11.
go back to reference Francis E, Singhi AK, Lakshmivenkateshaiah S, Kumar RK (2010) Transcatheter occlusion of patent ductus arteriosus in pre-term infants. JACC Cardiovasc Interv 3:550–555PubMedCrossRef Francis E, Singhi AK, Lakshmivenkateshaiah S, Kumar RK (2010) Transcatheter occlusion of patent ductus arteriosus in pre-term infants. JACC Cardiovasc Interv 3:550–555PubMedCrossRef
12.
go back to reference Ghasemi A, Pandya S, Reddy SV, Turner DR, Du W, Navabi M et al (2010) Trans-catheter closure of patent ductus arteriosus—what is the best device? Catheter Cardiovasc Interv 76:687–695PubMedCrossRef Ghasemi A, Pandya S, Reddy SV, Turner DR, Du W, Navabi M et al (2010) Trans-catheter closure of patent ductus arteriosus—what is the best device? Catheter Cardiovasc Interv 76:687–695PubMedCrossRef
13.
go back to reference Krichenko A, Benson LN, Burrows P, Moes CA, McLaughlin P, Freedom RM (1989) Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 63:877–880PubMedCrossRef Krichenko A, Benson LN, Burrows P, Moes CA, McLaughlin P, Freedom RM (1989) Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 63:877–880PubMedCrossRef
14.
go back to reference Lin CC, Hsieh KS, Huang TC, Weng KP (2009) Closure of large patent ductus arteriosus in infants. Am J Cardiol 103:857–861PubMedCrossRef Lin CC, Hsieh KS, Huang TC, Weng KP (2009) Closure of large patent ductus arteriosus in infants. Am J Cardiol 103:857–861PubMedCrossRef
15.
go back to reference Masura J, Tittel P, Gavora P, Podnar T (2006) Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders. Am Heart J 151:755.e7–755.e10CrossRef Masura J, Tittel P, Gavora P, Podnar T (2006) Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders. Am Heart J 151:755.e7–755.e10CrossRef
16.
go back to reference Pass RH (2006) Amplatzer duct occluder device: a new technology for the closure of the moderate-to-large-sized patent ductus arteriosus. Expert Rev Med Devices 3:291–296PubMedCrossRef Pass RH (2006) Amplatzer duct occluder device: a new technology for the closure of the moderate-to-large-sized patent ductus arteriosus. Expert Rev Med Devices 3:291–296PubMedCrossRef
17.
go back to reference Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE (2004) Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 44:513–519PubMedCrossRef Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE (2004) Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J Am Coll Cardiol 44:513–519PubMedCrossRef
18.
go back to reference Rao PS, Sideris EB, Haddad J, Rey C, Hausdorf G, Wilson AD et al (1993) Transcatheter occlusion of patent ductus arteriosus with adjustable buttoned device. Initial clinical experience. Circulation 88:1119–1126PubMedCrossRef Rao PS, Sideris EB, Haddad J, Rey C, Hausdorf G, Wilson AD et al (1993) Transcatheter occlusion of patent ductus arteriosus with adjustable buttoned device. Initial clinical experience. Circulation 88:1119–1126PubMedCrossRef
19.
go back to reference Thanopoulos B, Eleftherakis N, Tzannos K, Stefanadis C (2008) Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder: initial clinical applications in children. Am Heart J 156:917.e1–917.e6CrossRef Thanopoulos B, Eleftherakis N, Tzannos K, Stefanadis C (2008) Transcatheter closure of the patent ductus arteriosus using the new Amplatzer duct occluder: initial clinical applications in children. Am Heart J 156:917.e1–917.e6CrossRef
20.
go back to reference Tomita H, Uemura S, Haneda N, Soga T, Matsuoka T, Nishioka T et al (2009) Coil occlusion of PDA in patients younger than 1 year: risk factors for adverse events. J Cardiol 53:208–213PubMedCrossRef Tomita H, Uemura S, Haneda N, Soga T, Matsuoka T, Nishioka T et al (2009) Coil occlusion of PDA in patients younger than 1 year: risk factors for adverse events. J Cardiol 53:208–213PubMedCrossRef
Metadata
Title
Comparison of the Efficacy of Different-Sized Amplatzer Duct Occluders (I, II, and II AS) in Children Weighing Less Than 10 kg
Authors
Osman Baspinar
Ahmet Irdem
Ercan Sivasli
Derya Aydin Sahin
Metin Kilinc
Publication date
01-01-2013
Publisher
Springer-Verlag
Published in
Pediatric Cardiology / Issue 1/2013
Print ISSN: 0172-0643
Electronic ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-012-0393-6

Other articles of this Issue 1/2013

Pediatric Cardiology 1/2013 Go to the issue